Utilization of biomarkers for the prognostic prediction of cardiac arrest survivors using a multi-modal approach

作     者：Changshin Kang Yeonho You Jung Soo Park Byeong Kwon Park Jae Kwang Lee Byung Kook Lee Changshin Kang;Yeonho You;Jung Soo Park;Byeong Kwon Park;Jae Kwang Lee;Byung Kook Lee

作者机构：Department of Emergency MedicineCollege of MedicineChungnam National UniversityDaejeon 35015Republic of Korea Department of Emergency MedicineChungnam National University HospitalDaejoen 35015Republic of Korea Department of Emergency MedicineKonyang University HospitalCollege of MedicineDaejeon 35015Republic of Korea Department of Emergency MedicineChonnam National University Medical SchoolChonnam National University HospitalGwangju 61469Republic of Korea 

出 版 物：《World Journal of Emergency Medicine》 (世界急诊医学杂志（英文）)

年 卷 期：2024年第15卷第2期

页      面：131-134页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：supported by the research fund of Chungnam National University in 2022 

主　　题：cardiac modal return 

摘      要：International guidelines for post-cardiac arrest care recommend using multi-modal strategies to avoid the withdrawal of life-sustaining therapy(WLST)in patients with the potential for neurological recovery.[1]However,a clear methodology for multi-modal approaches has yet to be ***-specific enolase(NSE)is currently the only recommended biomarker,and the European Resuscitation Council(ERC)and the European SocietyofIntensiveCareMedicine(ESICM)have proposed a cutoff value of 60μg/L at 48 and/or 72 h after the return of spontaneous circulation(ROSC)as a multimodal prognostic tool for predicting poor neurological outcomes.